back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-03-27 16:11 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
56 - Grant of rights
|
$760,561
+120,724 vol $6.30 each |
354,057 | |
| Filed 2026-03-27 16:06 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,096,728
+332,814 vol $6.30 each |
1,911,222 | |
| Filed 2026-03-27 16:03 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$615,020
+95,947 vol $6.41 each |
446,199 | |
| Filed 2026-03-27 15:58 Tx date 2026-03-23 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Performance stock Unit
57 - Exercise of rights
|
$-391,030.80
-88,070 vol $4.44 each |
233,333 | |
| Filed 2026-03-23 17:24 Tx date 2026-03-19 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-883,108.46
-115,138 vol $7.67 each |
1,578,408 | |
| Filed 2026-03-20 15:42 Tx date 2026-03-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,010
+568 vol $5.30 each |
350,252 | |
| Filed 2026-03-20 15:41 Tx date 2026-03-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$15,005
+2,432 vol $6.17 each |
349,684 | |
| Filed 2026-02-10 14:32 Tx date 2026-02-06 |
$DOL
Dollarama Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
35 - Stock dividend
|
$758.34
+4 vol $189.59 each |
8,901 | |
| Filed 2026-02-06 15:08 Tx date 2026-02-02 |
$DOL
Dollarama Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
+644 vol |
8,897 | |
| Filed 2025-12-19 14:24 Tx date 2025-12-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,510
+675 vol $5.20 each |
347,252 | |
| Filed 2025-12-19 14:22 Tx date 2025-12-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$17,505
+2,903 vol $6.03 each |
346,577 | |
| Filed 2025-11-11 16:44 Tx date 2025-11-07 |
$DOL
Dollarama Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
35 - Stock dividend
|
$726.96
+4 vol $181.74 each |
8,253 | |
| Filed 2025-11-05 17:09 Tx date 2025-11-03 |
$DOL
Dollarama Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
+126 vol |
8,249 | |
| Filed 2025-09-17 15:58 Tx date 2025-09-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,010
+681 vol $4.42 each |
343,674 | |
| Filed 2025-09-17 15:56 Tx date 2025-09-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$15,003
+2,348 vol $6.39 each |
342,993 | |
| Filed 2025-08-12 16:45 Tx date 2025-08-08 |
$DOL
Dollarama Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
35 - Stock dividend
|
$768.01
+4 vol $192.00 each |
8,123 | |
| Filed 2025-08-07 10:57 Tx date 2025-08-04 |
$DOL
Dollarama Inc. |
Sakhia, Samira
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units (DSU)
56 - Grant of rights
|
+122 vol |
8,119 | |
| Filed 2025-07-11 16:34 Tx date 2025-04-03 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-908,259.54
-117,498 vol $7.73 each |
1,693,546 | |
| Filed 2025-06-18 16:34 Tx date 2025-06-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,439
+699 vol $4.92 each |
340,645 | |
| Filed 2025-06-18 16:33 Tx date 2025-06-15 |
$GUD
Knight Therapeutics Inc. |
Sakhia, Samira
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$17,256
+2,857 vol $6.04 each |
339,946 |